Meeting, greeting, and learning at the American Academy of Optometry's Annual Meeting | Optometry Times - Clinical News

Published on October 1, 2025
Keeping an eye on CE, industry news, and collaboration in Boston, Massachusetts.
Continue reading on website
Other news

Aurion Biotech Expands Its Leadership Team

October 1, 2025
SEATTLE, Wash., CAMBRIDGE, Mass. and TOKYO—Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases, announced the promotions of Andrew Torres, Ph.D., to chief manufacturing officer and Sterling Chung to chief regulatory and quality officer. These strategic appointments were made as the company prepares to initiate a U.S. Phase 3 clinical trial in the first

Taiwanese Study Using Population-based Polygenic Risk Score Effectively Predicted POAG

October 1, 2025
The most significant locus identified in the genome-wide association study was near the KYNU gene, which hasn’t been reported before in genetic POAG studies. KYNU encodes kynurenine, and the pathway this enzyme plays a key role in has been linked to mitochondrial dysfunction and a range of neurodegenerative conditions—including glaucoma—with reduced levels.  Photo: Michael Chaglasian, OD. Click im